Abstract 1388: Same-Site Recurrent M2 Occlusion Despite Therapeutic Anticoagulation in a Patient with Factor V Leiden
Stroke: Vascular and Interventional Neurology · 18.10.2026 · 6 (Suppl_1)
DOI: 10.1161/svi270000_1388 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stroke: Vascular and Interventional Neurology, erschienen am 18.10.2026. Verfasst von R. Kirmani und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Factor V Leiden (FVL) is the most common inherited thrombophilia and is well established in venous thromboembolism, but its contribution to arterial ischemic stroke remains contested. Most supportive evidence involves paradoxical embolism rather than in situ arterial thrombosis. Recurrent occlusion at an anatomically identical site despite therapeutic anticoagulation is uncommon and generates a differential distinct from that of first-time medium-vessel occlusion (MeVO).
Methods
We present a unique case of a patient with heterogenous FVL mutation who developed recurrent left middle cerebral artery (MCA) occlusion two months after initial successful recanalization with IV thrombolysis and mechanical thrombectomy. .
Results
A 43-year-old female patient with history of heterozygous FVL mutation presented as a stroke code due to expressive aphasia and dysarthria, with a presenting NIHSS of 6. Imaging revealed a left MCA occlusion of the M2 segment. She received IV thrombolysis followed by mechanical thrombectomy with successful recanalization, resulting in complete symptom resolution. Stroke etiology workup was unrevealing aside from her known FVL mutation, for which anticoagulation was initiated. Two months later, the patient presented again with a recurrent occlusion in the exact same M2 location, despite adherence to anticoagulation. Further workup was completed, including high-resolution imaging of the vessel wall, to investigate other contributors to re-occlusion as well as to guide secondary stroke prevention regimen. This was unremarkable for vasculitis, dissection, or intracranial atherosclerosis, again suggesting that hypercoagulability played a critical role in her presentation. .
Conclusion
Recurrence confined to a single arterial segment argues for a fixed local substrate. Post-thrombectomy endothelial injury or a reproducible flow-directed embolic trajectory rather than systemic hypercoagulability alone would be expected to produce thrombosis at variable sites. Heterozygous FVL occurs in 3-5% of individuals of European ancestry and incidental carriage cannot be excluded here. This case illustrates that failure of anticoagulation should prompt reconsideration of mechanism rather than empiric intensification, and that negative high-resolution vessel wall imaging at the M2 level carries limited sensitivity at the edge of spatial resolution.
Zitieren
APA
Kirmani, R., Lin, A., Akhai, A., Plagenz, J., & Bajgur, S. (2026). Abstract 1388: Same-Site Recurrent M2 Occlusion Despite Therapeutic Anticoagulation in a Patient with Factor V Leiden. Stroke: Vascular and Interventional Neurology, 6(Suppl_1). https://doi.org/10.1161/svi270000_1388
Vancouver
Kirmani R, Lin A, Akhai A, Plagenz J, Bajgur S. Abstract 1388: Same-Site Recurrent M2 Occlusion Despite Therapeutic Anticoagulation in a Patient with Factor V Leiden. Stroke: Vascular and Interventional Neurology. 2026;6(Suppl_1). doi:10.1161/svi270000_1388
BibTeX
@article{Kirmani2026,
author = {Kirmani, R. and Lin, A. and Akhai, A. and Plagenz, J. and Bajgur, S.},
title = {Abstract 1388: Same-Site Recurrent M2 Occlusion Despite Therapeutic Anticoagulation in a Patient with Factor V Leiden},
journal = {Stroke: Vascular and Interventional Neurology},
year = {2026},
volume = {6},
number = {Suppl_1},
doi = {10.1161/svi270000_1388}
}
EUVIMED